MXPA04005767A - Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados. - Google Patents

Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.

Info

Publication number
MXPA04005767A
MXPA04005767A MXPA04005767A MXPA04005767A MXPA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A MX PA04005767 A MXPA04005767 A MX PA04005767A
Authority
MX
Mexico
Prior art keywords
tabletting
formulation
natural mixtures
conjugated estrogens
solid
Prior art date
Application number
MXPA04005767A
Other languages
English (en)
Spanish (es)
Inventor
Lerch Martina
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of MXPA04005767A publication Critical patent/MXPA04005767A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04005767A 2001-12-14 2002-12-12 Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados. MXPA04005767A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129840 2001-12-14
PCT/EP2002/014104 WO2003051337A1 (de) 2001-12-14 2002-12-12 Präformulierung für die tablettierung von natürlichen gemischen konjugierter oestrogene

Publications (1)

Publication Number Publication Date
MXPA04005767A true MXPA04005767A (es) 2004-09-10

Family

ID=8179550

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005767A MXPA04005767A (es) 2001-12-14 2002-12-12 Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.

Country Status (13)

Country Link
US (2) US8273728B2 (enExample)
EP (1) EP1458363B1 (enExample)
JP (1) JP4695838B2 (enExample)
CN (2) CN1298313C (enExample)
AR (1) AR037642A1 (enExample)
AU (1) AU2002358682B2 (enExample)
BR (1) BR0214954A (enExample)
CA (1) CA2470209A1 (enExample)
ES (1) ES2403218T3 (enExample)
MX (1) MXPA04005767A (enExample)
PL (1) PL205544B1 (enExample)
TW (1) TWI332400B (enExample)
WO (1) WO2003051337A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
US20120100211A1 (en) * 2009-07-16 2012-04-26 James Farina Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
WO2013083674A1 (de) * 2011-12-08 2013-06-13 Hexal Ag Neue pharmazeutische statin-zusammensetzung
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US20210246928A1 (en) * 2020-02-11 2021-08-12 Carl Chasse Fastener having improved wobble control, fastening system including the same, and method of forming the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (de) 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
PL185919B1 (pl) 1996-08-30 2003-08-29 Solvay Pharm Gmbh Sposób otrzymywania estrogenów z moczu klaczySposób otrzymywania estrogenów z moczu klaczy
SK281367B6 (sk) 1996-08-30 2001-02-12 Solvay Pharmaceuticals Gmbh Spôsob získavania estrogénov z moču kobýl
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (ja) 1998-11-19 2000-06-06 Hokuto Denko Kk 電池の充放電試験装置
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Also Published As

Publication number Publication date
BR0214954A (pt) 2004-12-14
EP1458363A1 (de) 2004-09-22
CN1298313C (zh) 2007-02-07
WO2003051337A1 (de) 2003-06-26
HK1075007A1 (en) 2005-12-02
EP1458363B1 (de) 2013-01-16
JP2005516923A (ja) 2005-06-09
JP4695838B2 (ja) 2011-06-08
CA2470209A1 (en) 2003-06-26
CN100502839C (zh) 2009-06-24
CN1977862A (zh) 2007-06-13
US20120237666A1 (en) 2012-09-20
US8273728B2 (en) 2012-09-25
AR037642A1 (es) 2004-11-17
PL368730A1 (en) 2005-04-04
PL205544B1 (pl) 2010-04-30
TWI332400B (en) 2010-11-01
ES2403218T3 (es) 2013-05-16
TW200408400A (en) 2004-06-01
HK1104220A1 (zh) 2008-01-11
AU2002358682A1 (en) 2003-06-30
US8329679B2 (en) 2012-12-11
CN1607944A (zh) 2005-04-20
US20050009800A1 (en) 2005-01-13
AU2002358682B2 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
MXPA01011039A (es) Derivados de 6-alquenilo, 6-alquinilo y 6-epoxi-epotilona, procesos para su produccion y su uso en preparaciones farmaceuticas..
IL153920A (en) Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
PL400027A1 (pl) Wieloelementowa farmaceutyczna postac dawkowania i sposób jej wytwarzania
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
ATE367802T1 (de) Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
AU2002235930A1 (en) A process for the manufacture of a herbal composition comprising a matrine
IL150528A0 (en) Ibuprofen containing active agent preparation
SE0103211D0 (sv) New formulations and use thereof
BR0214954A (pt) Pré-formulação para a produção de comprimidos de misturas de estrogênios conjugados naturais
AU2002210484A1 (en) Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments
WO2003059329A3 (en) Polytartrate composition
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2003063824A3 (en) Pharmaceutical composition
HUP0200625A2 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
WO2002024164A3 (fr) Procede de granulation par extrusion basse pression
AU7795800A (en) Method for supercritical fluid extraction
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
WO2004006831A3 (en) Method and device for inducing biological processes by micro-organs

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status